| scholarly article | Q13442814 |
| P50 | author | Edward A Fisher | Q38549204 |
| Jason S. Lewis | Q41485356 | ||
| Jun Tang | Q41534112 | ||
| Thomas Reiner | Q41534115 | ||
| Carlos Pérez-Medina | Q59289478 | ||
| Willem J.M. Mulder | Q62656505 | ||
| Miriam Merad | Q64748184 | ||
| P2093 | author name string | Zahi A Fayad | |
| Dalya Abdel-Atti | |||
| Brandon Hogstad | |||
| P2860 | cites work | Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy | Q27690653 |
| Megalin acts in concert with cubilin to mediate endocytosis of high density lipoproteins | Q28505461 | ||
| Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis | Q29396371 | ||
| PET imaging of tumor associated macrophages using mannose coated 64Cu liposomes | Q30455880 | ||
| Behavior of endogenous tumor-associated macrophages assessed in vivo using a functionalized nanoparticle. | Q30487170 | ||
| Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease | Q33901943 | ||
| Stable isotope turnover of apolipoproteins of high-density lipoproteins in humans | Q33959450 | ||
| The cellular and molecular origin of tumor-associated macrophages | Q34378833 | ||
| Imaging macrophages with nanoparticles | Q34399530 | ||
| Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. | Q34531618 | ||
| Tissue sites of degradation of high density lipoprotein apolipoprotein A-IV in rats | Q70287906 | ||
| Tissue sites of degradation of apoprotein A-I in the rat | Q70434459 | ||
| Role of the kidney in regulating the metabolism of HDL in rabbits: evidence that iodination alters the catabolism of apolipoprotein A-I by the kidney | Q73811656 | ||
| Macrophage regulation of tumor responses to anticancer therapies | Q34649588 | ||
| A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting | Q35238675 | ||
| Modular strategy for the construction of radiometalated antibodies for positron emission tomography based on inverse electron demand Diels-Alder click chemistry | Q35394166 | ||
| Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. | Q35800693 | ||
| In vivo biodistribution and accumulation of 89Zr in mice | Q35923622 | ||
| Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation | Q35964485 | ||
| 89Zr-Radiolabeled Trastuzumab Imaging in Orthotopic and Metastatic Breast Tumors | Q37148669 | ||
| Regulation of cholesterol efflux from macrophages | Q37260164 | ||
| Apolipoprotein AI tertiary structures determine stability and phospholipid-binding activity of discoidal high-density lipoprotein particles of different sizes | Q37407561 | ||
| Tumor-associated macrophages: effectors of angiogenesis and tumor progression. | Q37408808 | ||
| High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis. | Q37611333 | ||
| A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation | Q37727091 | ||
| Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer | Q38076653 | ||
| Tumor-associated macrophages: from mechanisms to therapy | Q38230880 | ||
| MR imaging of tumor-associated macrophages | Q42214227 | ||
| Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: lessons and open questions | Q42603542 | ||
| Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine | Q43111522 | ||
| Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages. | Q46189905 | ||
| Exchange of phospholipids between low and high density lipoproteins of squirrel monkeys. | Q54106993 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipoprotein | Q28350 |
| nanoparticle | Q61231 | ||
| P304 | page(s) | 1272-1277 | |
| P577 | publication date | 2015-06-25 | |
| P1433 | published in | The Journal of Nuclear Medicine | Q7743608 |
| P1476 | title | PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles | |
| P478 | volume | 56 |
| Q33615407 | A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines |
| Q92668355 | An 89Zr-HDL PET Tracer Monitors Response to a CSF1R Inhibitor |
| Q38557650 | Applying nanomedicine in maladaptive inflammation and angiogenesis |
| Q94596281 | Cellular and Extracellular Components in Tumor Microenvironment and Their Application in Early Diagnosis of Cancers |
| Q63560435 | Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates |
| Q98895951 | Head-to-Head Comparison of the Penetration Efficiency of Lipid-Based Nanoparticles into Tumor Spheroids |
| Q92956685 | High density lipoprotein mimicking nanoparticles for atherosclerosis |
| Q61443104 | Imaging endogenous macrophage iron deposits reveals a metabolic biomarker of polarized tumor macrophage infiltration and response to CSF1R breast cancer immunotherapy |
| Q49592815 | Imaging the Tumor Microenvironment. |
| Q28393434 | Immune cell screening of a nanoparticle library improves atherosclerosis therapy |
| Q55039815 | In Vivo MR Imaging of Tumor-Associated Macrophages: The Next Frontier in Cancer Imaging. |
| Q58592065 | Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance |
| Q41534056 | In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models. |
| Q39159035 | Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites. |
| Q38822339 | Lipoproteins and lipoprotein mimetics for imaging and drug delivery |
| Q60253988 | Magnetic Resonance Imaging of Tumor-Associated Macrophages: Clinical Translation |
| Q38738754 | Molecular Imaging in Nanotechnology and Theranostics |
| Q39283111 | Nanomedicine Strategies to Target Tumor-Associated Macrophages |
| Q61816620 | Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma |
| Q48546477 | Nanoparticle-Based Modulation and Monitoring of Antigen-Presenting Cells in Organ Transplantation |
| Q38785806 | Nanoparticles and radiotracers: advances toward radionanomedicine |
| Q64819927 | Neurotheranostics as personalized medicines |
| Q38646584 | Peripheral Nerve Nanoimaging: Monitoring Treatment and Regeneration |
| Q57079914 | Polycationic carbosilane dendrimer decreases angiogenesis and tumor-associated macrophages in tumor-bearing mice |
| Q99709271 | Positron Emission Tomography for Response Evaluation in Microenvironment-Targeted Anti-Cancer Therapy |
| Q38926681 | Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics |
| Q90216359 | Quantitative Imaging of Tumor-Associated Macrophages and Their Response to Therapy Using 64Cu-Labeled Macrin |
| Q37131224 | Radio-nanomaterials for biomedical applications: state of the art |
| Q28074696 | Radiolabeled theranostics: magnetic and gold nanoparticles |
| Q52657727 | Recent Advances in Zirconium-89 Chelator Development. |
| Q58609850 | Reconstituted Discoidal High-Density Lipoproteins: Bioinspired Nanodiscs with Many Unexpected Applications |
| Q92923676 | Roles of Reconstituted High-Density Lipoprotein Nanoparticles in Cardiovascular Disease: A New Paradigm for Drug Discovery |
| Q58609425 | Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling |
| Q52982499 | Synthesis and Characterization of (89)Zr-Labeled Ultrasmall Nanoparticles. |
| Q47142621 | Target-or-Clear Zirconium-89 Labeled Silica Nanoparticles for Enhanced Cancer-Directed Uptake in Melanoma: A Comparison of Radiolabeling Strategies. |
| Q92987543 | Therapeutic targeting of trained immunity |
| Q37738227 | Visualization of Macrophage Recruitment to Inflammation Lesions using Highly Sensitive and Stable Radionuclide-Embedded Gold Nanoparticles as a Nuclear Bio-Imaging Platform |
| Q59128232 | What Is the Role of Nanotechnology in Diagnosis and Treatment of Metastatic Breast Cancer? Promising Scenarios for the Near Future |
Search more.